When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
GMAB - European advisory group backs expanded use of J&J's Darzalex
Genmab A/S
The European Medicines Agency's advisory group CHMP has adopted a positive opinion recommending approval of Johnson & Johnson (NYSE:JNJ) unit Janssen Biotech's Darzalex (daratumumab), combined with Takeda's (NYSE:TAK) Velcade (bortezomib), thalidomide and dexamethasone, for the treatment of adults with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant.
More news on: Johnson & Johnson, Takeda Pharmaceutical Company Limited, Genmab A/S, Healthcare stocks news,